PicoWay® picosecond laser received U.S. Food and Drug Administration (FDA) clearance for a new ultra-short 785 nm wavelength, making it the third FDA cleared wavelength for PicoWay. The new ultra-short 785nm wavelength is the first of its kind in the aesthetic market, utilizing a titanium sapphire laser for the removal of blue and green inks.

 

 

The FDA clearance of the new ultra-short 785 nm wavelength was supported by a 15 patient study, covering 22 tattoos, of which 18 contained blue and green inks. Blinded evaluation of tattoo clearance, by independent board-certified physicians, showed that 83% of the treated blue/green tattoos had “good” to “complete” treatment response after 2 PicoWay treatments with the 785 nm wavelength. Moreover, investigator assessments of tattoo clearance showed similar results to blinded evaluation findings. There were no treatment complications, and PicoWay treatments were generally associated with mild to no discomfort for the majority of treatments.

 

 

Eric F. Bernstein, MD, MSE, Director of the Main Line Center for Laser Surgery in suburban Philadelphia, PA, was the principal investigator for the clinical study resulting in FDA clearance of the new 785 nm wavelength for PicoWay laser. Dr. Bernstein commented, “This is the first, ever, 785 nm wavelength picosecond-domain laser in the world. This novel addition to the PicoWay enables optimal treatment for blue and green tattoos, and is a welcome addition to the 532 and 1,064 nm wavelengths already available with the PicoWay.

 

 

The innovative PicoWay laser platform delivers ultra-short pulses of energy (e.g., 300 picoseconds at 785 nm) making treatments shorter and comfortable for patients while offering the industry’s shortest pulses and highest peak power. The addition of PicoWay’s third wavelength completes the PicoWay laser platform, allowing for the comprehensive removal and treatment of all colors of tattoo and pigmented lesions. The PicoWay picosecond laser previously received FDA clearance for the removal of tattoos and the treatment of pigmented lesions.

 

 

PicoWay’s unique mode of action is based on delivering ultra-short picosecond pulses of energy to the tissue. These bursts of energy create a photoacoustic impact which breaks up the target pigment into smaller, more easily eliminated particles. The three wavelengths 532 nm, 785 nm and 1064 nm target a wide range of tattoos and pigmented lesions. The Resolve^TM dual wavelength picosecond fractional module treats pigmentation, skin irregularities and signs of aging. The high peak power enables a broad range of spot sizes for ultimate treatment customization.

 

 

For further Information visit www.syneron-candela.com